A Prognostic Model Based on POCUS at ICU Admission in Critically Ill Patients With Sepsis

Sepsis Clinical Trial

Official title:

A Prognostic Model Based on POCUS at ICU Admission in Critically Ill Patients With Sepsis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06082154
• Other study ID #: 506(6-11)E2
• Status: Recruiting
• Start date: April 26, 2023
• Est. completion date: April 30, 2024

Study information

• Verified date: November 2023
• Source: Tribhuvan University Teaching Hospital, Institute Of Medicine.
• Contact: Ashmita Paudel, MD
• Phone: 9845362257
• Email: paudel.ashmita2000[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Sepsis is responsible for one in three patient deaths. Understanding the severity of the disease, directing medications, prognosticating, and communicating with family members depend on the ability to predict outcomes in a patient presenting with sepsis in the ICU. The outcome of mortality reflects the caliber of ICU treatment. This is a prospective observational study that will include all patients diagnosed with sepsis for point-of-care ultrasonography within 24 hours of admission to the ICU from April 26, 2023, to March 30, 2024, and create a model that will predict 28 day outcome in these patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 186
• Est. completion date: April 30, 2024
• Est. primary completion date: March 30, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Age >=16 yrs within 24 hour of ICU admission diagnosed as Sepsis as per Sepsis 3

Exclusion Criteria:

• USG cannot be done within 24 hour of admission to icu If USG cannot be done for 2 parameters Who do not give consent Withdrawal of active life support Do not intubate(DNI) or do not resuscitate(DNR) order at admission

Related Conditions & MeSH terms

• Sepsis
• Toxemia

Intervention

Device:
• ultrasound
Patient will undergo multiorgan ultrasonography

Locations

Country	Name	City	State
Nepal	Ashmita Paudel	Kathmandu	Bagmati

Sponsors (1)

Lead Sponsor	Collaborator
Tribhuvan University Teaching Hospital, Institute Of Medicine.

Country where clinical trial is conducted

Nepal, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	28 day status alive or dead	patient will be followed for 28 days from day of icu admission to find out their status being alive or dead	28 days